Actinium Pharmaceuticals Inc. (ATNM)
NYSE · Healthcare
Actinium Pharmaceuticals Inc. EBITDA 2010–2025
Actinium Pharmaceuticals Inc. annual/quarterly ebitda history and growth rate from 2011 to 2022. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Actinium Pharmaceuticals Inc. ebitda for the quarter ending March 31, 2022 was -5.0 M, a 4.19% decrease year-over-year.
- Actinium Pharmaceuticals Inc. ebitda for the twelve months ending March 31, 2022 was -13.5 M.
- Actinium Pharmaceuticals Inc. annual ebitda for 2025 was -36.1 M, a 30.24% decrease from 2023.
- Actinium Pharmaceuticals Inc. annual ebitda for 2023 was -51.7 M, a 54.81% increase from 2022.
- Actinium Pharmaceuticals Inc. annual ebitda for 2022 was -33.4 M, a 36.68% increase from 2021.
- Actinium Pharmaceuticals Inc. annual ebitda for 2021 was -24.4 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Actinium Pharmaceuticals Inc. EBITDA — FAQ
Actinium Pharmaceuticals Inc. (ATNM) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ATNM's ebitda history?
The chart and table above show Actinium Pharmaceuticals Inc.'s ebitda by year and by quarter, including the growth rate.